Editas Medicine (EDIT) FCF Margin (QoQ) (2015 - 2025)
Editas Medicine (EDIT) FCF Margin (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Editas Medicine | 263.01 Mn | 116.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 99,447.00 |
| Jun 30, 2025 | -39,919.00 |
| Mar 31, 2025 | -83,653.00 |
| Dec 31, 2024 | 9.08 Mn |
| Sep 30, 2024 | -7.92 Mn |
| Jun 30, 2024 | -724,543.00 |
| Mar 31, 2024 | -451,964.00 |
| Dec 31, 2023 | 62,979.00 |
| Sep 30, 2023 | 71,804.00 |
| Jun 30, 2023 | -100,528.00 |
| Mar 31, 2023 | 27,455.00 |
| Dec 31, 2022 | 11.51 Mn |
| Sep 30, 2022 | -11.52 Mn |
| Jun 30, 2022 | 15,543.00 |
| Mar 31, 2022 | -46,007.00 |
| Dec 31, 2021 | 39,581.00 |
| Sep 30, 2021 | 979,480.00 |
| Jun 30, 2021 | -969,889.00 |
| Mar 31, 2021 | -42,866.00 |
| Dec 31, 2020 | -27,316.00 |